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Abstract
Background: Laboratory analysis of coagulation is often important in emergencies. If vascular access is challenging,
intraosseous catheterization may be necessary for treatment. We studied the analysis of coagulation parameters in
intraosseous aspirate during stable conditions and after major haemorrhage in a porcine model.
Methods: Ten anesthetized pigs received central venous and intraosseous catheters and samples were taken for
analysis of thromboelastography (TEG), prothrombin time (PT), activated partial thromboplastin time (APTT) and
fibrinogen concentration. Analyses were repeated after removal of 50 % of the calculated blood volume and
resuscitation with crystalloid. Intraosseous and venous values were compared.
Results: Bleeding and resuscitation resulted in haemodilution and hypotension. Median TEG reaction time was
shorter in intraosseous than in venous samples before (1.6 vs 4.6 min) and after (1.6 vs 4.7 min) haemodilution.
Median maximal amplitude was smaller in intraosseous samples at baseline (68.3 vs 76.4 mm). No major differences
were demonstrated for the other TEG parameters. The intraosseous samples often coagulated in vitro, making
analysis of PT, APTT and fibrinogen difficult. After haemodilution, TEG maximal amplitude and α-angle, and
fibrinogen concentration, were decreased and PT increased.
Discussion: The intraosseous samples were clinically hypercoagulable and the TEG demonstrated a shortened
reaction time. The reason for this may hypothetically be found in the composition of the IO aspirate or in the
sampling technique. After 50 % haemorrhage and haemodilution, a clinically relevant decrease in fibrinogen
concentration and a lower TEG maximal amplitude were observed.
Conclusions: Although the sample is small, these data indicate that intraosseous samples are hypercoagulable,
which may limit their usefulness for coagulation studies. Major haemodilution only moderately affected the studied
parameters.
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Background
Laboratory analysis of coagulation provides important
information in many emergencies where coagulopathies
are common, including trauma, major surgery and
sepsis, and in the large population of patients using
medications affecting this system [1–3].
In the critically ill patient where intravenous access is
unsuccessful, intraosseous access is recommended [4, 5].
Intraosseous access has been demonstrated to be a fast,
reliable and safe method that permits administration of
drugs and resuscitation fluids in various settings [6, 7].
In an emergency, questions may arise whether blood
from an intraosseous catheter can also be used for
laboratory analyses, and this has been the subject of
some investigation [8, 9].
For monitoring of coagulation, the platelet count,
prothrombin time (PT), activated partial thromboplastin
time (APTT) and plasma fibrinogen concentration are
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frequently studied parameters. A rising interest is also seen
for global point of care methods, i.e. thromboelastography
(TEG) / thromboelastometry, as monitors of coagulation
in emergencies and in surgical haemorrhage [2, 10, 11].
Previous data suggest that platelet counts in intraoss-
eous aspirate do not adequately reflect levels in venous
blood and there may also be a potential risk that bone
marrow debris in the samples could damage cell counters
[12–14]. In addition to a different platelet content, bone
marrow also contains lipid, and these factors could be
hypothesized to affect coagulation analyses [15, 16].
The aim of this study was to evaluate whether aspirate
from an intraosseous catheter could be used for TEG
and standard coagulation assays, and whether values
were comparable to those in simultaneously aspirated
venous blood under stable conditions and after major
haemorrhage and resuscitation.
As it would be both ethically and practically difficult to
compare intraosseous and venous laboratory samples in
critically ill or injured patients in a standardized manner,
an animal model was considered the best option for this
study. Since the circulatory system of the pig is most
similar to that of humans among the non-primates, a por-
cine model was chosen. Such models have also previously
been considered suitable for coagulation research [17, 18].
Methods
Animals
Ten healthy domestic-breed pigs weighing between 23. 1
and 28. 5 kg (mean 26. 4 ± 1. 7 kg) were included in the
study. All animals were handled according to the guidelines
of the Swedish National Board for Laboratory Animals and
the European Convention on Animal Care. The Animal
Ethics Committee of Uppsala University, Sweden, approved
the experiment (C155/14, date of approval 2014-10-24).
Anaesthesia and preparatory procedures
Anaesthesia was induced by an injection of 6 mg × kg−1
tilétamin-zolazepam mixed with 2.2 mg × kg−1 xylazin in
the neck muscles. General anaesthesia was maintained
with a continuous infusion of 8 mg × kg−1 × h−1 of
pentobarbital mixed with 1.6 mg × kg−1 × h−1 of rocuro-
nium and 0.48 mg × kg−1 × h−1 of morphine.
After receiving a bolus dose of 20 mg of morphine and
100 mg of ketamine, animals were tracheotomised and
mechanically ventilated using a Servo I ® ventilator (Maquet
Critical Care, Solna, Sweden). During the experiment, the
animals received 8 mL× kg−1 × h−1 of a balanced solution
containing 25 mg ×mL−1 of glucose, and 7 mL× kg−1 × h−1
of Ringer Acetate. An arterial catheter was placed into a
right cervical artery and a central venous catheter was intro-
duced through the right external jugular vein into the su-
perior caval vein. A Swan-Ganz catheter was introduced
through the right external jugular vein into the pulmonary
artery. A 15G IO cannula (EZ-IO®, Teleflex Medical, Mor-
risville, NC, USA) was inserted into the proximal tibia. Cor-
rect placement was verified by the needle standing without
support, aspiration of blood and by an incision to the bone
after finishing the experiment. A 13.5 Fr. dialysis catheter
was inserted through the left external jugular vein. A minor
vesicotomy was performed and a urinary catheter was
inserted. After preparation procedures, a stabilization period
of 30 min in supine position preceded the experiment.
Protocol
At baseline, simultaneous samples were collected from the
intraosseous (IO) and central venous (CV) catheters. Blood
was collected using 5 cc plastic syringes and immediately
transferred to sodium citrate tubes for TEG and citrate-
theophylline- adenosine- dipyridamole (CTAD) tubes for
analysis of PT, APTT and fibrinogen concentration. 2 ml of
blood was wasted before taking the samples for analysis and
the catheters were flushed with 2 ml of saline after sam-
pling. Samples were manually transported to the laboratory.
After the baseline samples, 50 % of the total calculated
blood volume of 67 ml/kg was aspirated through the left
jugular venous catheter and replaced with an equal volume
of Ringer Acetate [19]. In conjunction with this, a small
dose of heparin was administrated intravenously in six of
the animals to achieve pathologic APTT results and to
study the effect of different doses on the TEG. After a
period of equilibration, new IO and CV samples were
collected and the TEG, PT, APTT and fibrinogen analyses
were repeated. The IO catheters were not used for infusion
between the samples. After finishing the experiment, the
animals were euthanized by potassium chloride injection.
Laboratory analysis
The TEG analysis was performed in recalcified, kaolin
activated whole blood according to manufacturer’s instruc-
tions (TEG 5000®, Haemoscope, Niles, IL). Analysis was
performed both with and without heparinase. TEG parame-
ters R (reaction time), K (kinetics), α-angle, maximal ampli-
tude (MA) and lysis at 30 min (Ly30) were analysed.
Activated partial thromboplastin time (APTT, reagent
STA PTT automate 5), fibrinogen (clot method, reagent
00673) and prothrombin time (PT, reagent STA SPA +)
were analysed with a STA-R® instrument (Diagnostica
Stago S.A.S, Asnières sur Seine, France) with reagents
from the same manufacturer. The prothrombin time was
reported as International Normalized Ratio (INR) values.
The total coefficients of variation for the methods were
1.9 % at 34.6 s for APTT, 3.0 % at 3 g/L for fibrinogen
and 1.1 % at INR 1.0 for the prothrombin time.
Statistical analysis
Data were examined for normality. Median and interquar-
tile range (IQR) / range for IO and CV values from each
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sampling time were calculated for the measured parame-
ters. Average differences between simultaneous IO and CV
samples from the same individuals were calculated and re-
ported as median and IQR / range. Differences between
simultaneous IO and CV samples, and between baseline
and second samples, were also assessed with Wilcoxon
signed-rank test. Excel 2013® (Microsoft Corp. Redmond
WA) and Statistica 13® (Statsoft Inc. Tulsa, OK) were used
for the calculations.
Results
All animals were successfully catheterized and aspiration
of adequate sample volumes from the intraosseous cathe-
ters was generally feasible although it required somewhat
more time and negative pressure than aspiration from the
central venous catheters. On a few occasions it was diffi-
cult to draw the second intraosseous sample. A new cath-
eter was then placed on the contralateral side and used for
the second sample. Also, on a few occasions, clotting was
observed in the tubes for the IO samples which then were
re-drawn immediately. Samples were delivered to the la-
boratories within 5 min from drawing. Four animals re-
ceived no heparin, one received 500, three received 1000,
one 2000 and one 2500 IU. Due to logistic problems, base-
line samples for PT, APTT and fibrinogen are missing
from 1 animal and second TEG values from 2 animals.
Significant haemodilution occurred between first and
second sampling with a reduction in mean (SD) haemo-
globin level from 100 (6) to 57 (7) g × L−1. Mean arterial
pressure (MAP) was also reduced from (mean (SD)) 73
(15) to 52 (7) mm Hg.
TEG analyses were carried out on all delivered samples
with and without heparinase, the heparinase analysis was
used for comparison between IO and CV samples. Two
of the IO TEG-curves, one at baseline and one at second
sample, were markedly different from the others. In the
first one, K could not be calculated as MA never reached
20 mm. This curve was excluded from analysis for pre-
sumed technical fault.
Average IO and CV values and differences between
simultaneous IO and CV samples are presented in Tables 1
and 2.
The reaction time (R) was invariably shorter in intraoss-
eous compared with venous samples at both baseline and
second sampling. The clot formation parameters, K and
α-angle, were similar in IO and CV samples, while the
MA was smaller in the IO samples at the first sampling.
Heparin had a dose dependent effect on the TEG when
performed without heparinase. In the animal that received
2500 IU, no TEG curve could be produced in either IO or
CV samples. In the animal receiving 2000 IU, no TEG curve
was produced in the CV sample while there was a 2 min R
prolongation compared with the heparinase analysis in the
IO sample. After 1000 IU, R was prolonged with, on average,
2.3 min in the CV and 0.1 min in the IO samples and in the
animal receiving 500 IU it was prolonged with 1.2 min in
the CV but unaffected in the IO sample.
Although no visible clots were observed in the tubes
when delivered to the laboratories, in a majority of the
IO samples, the PT, APTT and fibrinogen analyses could
not be performed because of clotting observed during
the handling of the samples in the laboratory. All CV
samples were analysed successfully. Average IO and CV
values, differences and the number of samples included
in the analysis are presented in Tables 3 and 4.
P-values from comparisons between IO and CV values
and between values at baseline and after haemodilution
are presented in Table 5.
The MA and α-angle decreased significantly in both
IO and CV samples after haemodilution while for the
remaining TEG parameters, no significant change was
observed. For the standard parameters, only CV samples
were compared and an increased PT and a decreased
fibrinogen concentration were seen after haemodilution
(see Additional files 1 and 2).
Discussion
If an intraosseous catheter is the only vascular access in
a critically ill or injured patient, it is important to know
if aspirate from such an access can be used for acute
laboratory analyses.
The most frequently studied laboratory parameters are
blood gas and acid base status. Kissoon et al. and
Abdelmoneim et al. demonstrated similar pH and PCO2 in
IO and central venous samples during the earlier phase of
Table 1 TEG reaction time (R), kinetics (K), α-angle (α), Maximal Amplitude (MA), Lysis at 30 min (LY30) in intraosseous (IO) and
central venous (CV) samples at baseline and average differences between simultaneous samples IO–CV from the same individuals
Variable Unit n IO n CV IO CV IO–CV
R min 9 10 1.6 (1.2–2-2) 4.6 (4.4–6.7) −2.8 (−5.8–(−1.8))
K min 9 10 0.9 (0.8–1.0) 1.0 (0.8–1.1) 0 (−0.1–0)
α ° 9 10 77.3 (75.6–78.8) 77.2 (74.3–78.5) −0.4 (−1.5–0.1)
MA mm 9 10 68.3 (68.2–71.3) 76.4 (71.9–77.8) −8.9 (−9.6–(−2.6))
LY 30 % 9 10 3.2 (2.2–4.9) 3.2 (2.3–4.9) 0.7 (−1.5–0.9)
Values are median and interquartile range (Q1–Q3)
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cardiopulmonary resuscitation in a porcine model. [20, 21].
We demonstrated previously that analysis of haemoglobin,
blood gas and acid base status was feasible using point of
care equipment and this was recently repeated in a human
study by Veldhoen et al. [22, 23].
Orlowski et al. found similar levels of haemoglobin,
electrolytes and blood chemistries in IO, arterial and
venous samples [8]. More recently, Miller et al. demon-
strated correlation between IO and venous samples for,
among others, haemoglobin, glucose, blood urea nitro-
gen and creatinine [9].
Laboratory analysis of coagulation could be of import-
ance in emergencies where IO access might be used, and
in this experiment we studied the possibility of analysing
TEG, PT, APTT and fibrinogen in intraosseous and
venous samples.
In the majority of the IO samples, clotting in the tubes
hindered the analysis of PT, APTT and fibrinogen, while
all venous samples were analysed without problems. In
the small number of samples available for comparison,
clinically relevant differences were observed for APTT
but not for PT and fibrinogen.
In the TEG analysis, the reaction time, R, was invariably
shorter in the intraosseous than in the venous samples at
both baseline and second sampling and the baseline
maximal amplitude, MA, was less in the IO samples. The
faster activation is in line with the clinically observed
hypercoagulability compared with the venous samples. In
this context, the lower MA might be partially explained by
consumption of coagulation elements in the tube before
starting the analysis. However, a lower platelet content in
IO samples have been reported previously [13]. Also, the
anticoagulant effect of heparin was more readily seen in
the venous than in the IO samples when comparing ana-
lyses were performed on the same samples with and with-
out heparinase. The reason for this hypercoagulability
may be found in the composition of the intraosseous as-
pirate, but the less straightforward aspiration of the sam-
ple could also be a contributing factor [24].
After haemodilution, compared with baseline, a lower
TEG maximal amplitude and fibrinogen concentration
was seen. There were also an increased PT-INR and a
reduced α angle, but the amplitude of these changes
were not clinically relevant. These relatively minor
changes are consistent with previous findings and re-
flects the complexity of coagulopathy in trauma and
haemorrhage, where haemodilution is considered only to
be a part of the problem [18].
This study has several limitations. Firstly, it is an
experimental study and results therefore cannot be
directly translated to clinical conditions. Secondly, the
study is small, and should be considered exploratory in
nature, although the main findings appear quite clear.
The pig has been demonstrated to be hypercoagulable
compared to humans, but since venous samples could
be analysed without clotting in these animals, we do not
believe that this alone accounts for the findings [17].
Also, haemorrhage and resuscitation, although leading
to significant haemodilution, only moderately affected
the studied coagulation parameters. It would be of inter-
est to compare IO and venous samples in a setting of
more severe coagulopathy although the iatrogenic coag-
ulopathy caused by heparinisation in this study was less
apparent in the IO than in the venous samples.
Table 2 TEG reaction time (R), kinetics (K), α-angle (α), Maximal Amplitude (MA), Lysis at 30 min (LY30) in intraosseous (IO) and central
venous (CV) samples after haemodilution and average differences between simultaneous samples IO–CV from the same individuals
Variable Unit n IO n CV IO CV IO–CV
R min 8 8 1.6 (1.3–2.2) 4.7 (4.4–5.3) −2.8 (−3.5–(−2.3)
K min 8 8 1.2 (0.9–1.7) 1.2 (1.1–1.4) −0.1 (−0.3–0.7)
α ° 8 8 75.3 (67.5–77.9) 73 (71.6–74.9) 2.5 (−7.3–4.7)
MA mm 8 8 64.6 (54.8–69.3) 67.3 (65.8–69.3) −0.9 (−14.9–2.5)
LY 30 % 8 8 3 (1.2–5.4) 2.4 (1.2–6.4) 0.1 (−1.4–0.4)
Values are median and interquartile range (Q1–Q3)
Table 3 Prothrombin Time, International Normalized Ratio
(PT, INR), Activated Partial Thromboplastin Time (APTT), and
fibrinogen in intraosseous (IO) and central venous (CV) samples
at baseline and average differences between simultaneous
samples IO–CV from the same individuals
Variable Unit n IO n CV IO CV IO–CV
PT INR 4 9 1 (0.9–1.1) 1.1 (1–1.2) −0.1 (−0.1–0)
APTT s 3 9 63 (21–200) 67 (24–100) −3 (−18–133)
Fibrinogen g / L 4 9 1.8 (0.8–3.3) 1.8 (1.2–3.3) 0 (−1–0.1)
Values are median and range
Table 4 Prothrombin Time, International Normalized Ratio
(PT, INR), Activated Partial Thromboplastin Time (APTT), and
fibrinogen in intraosseous (IO) and central venous (CV) samples
after haemodilution and average differences between
simultaneous samples IO–CV from the same individuals
Variable Unit n IO n CV IO CV IO–CV
PT INR 3 10 1.2 (1.1–1.3) 1.2 (1–1.3) −0.1 (−0.1–0)
APTT S 3 10 62 (26–200) 64 (32–115) 0 (−6–98)
Fibrinogen g/L 3 10 1 (0.8–2) 1.1 (0.8–2) 0 (0–0)
Values are median and range
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Furthermore, in a clinical scenario where IO access is
used, the primary objective is likely to be fluid or drug
management. A relevant question is therefore whether
infusion in the IO catheter affects agreement between IO
and reference laboratory samples. In a previous study, we
found IO sample values of haemoglobin, blood gas and
acid base parameters to be less reliable when taken from
an access with an ongoing infusion. We therefore decided
to use IO catheters without infusion in this study and
would recommend that any samples for analysis, if pos-
sible, are taken before starting an infusion [25].
Conclusions
Although our sample is small, our observations in this
model indicate that the IO samples are hypercoagulable
compared to venous samples, which may limit their useful-
ness for coagulation studies. However, it cannot be excluded
that analysis of coagulation in human intraosseous aspirate
could perform differently and such data would be useful to
further elucidate the subject. It would also be of interest to
investigate to what extent sampling technique contributes to
the observed hypercoagulability. For example, local heparin-
isation of the catheters before sampling and reversal with
heparinase during TEG analysis might be a possibility. Thus,
further studies are necessary to confirm or rule out the
possibility of coagulation studies on intraosseous samples.
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